comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-02 13:05:28 Page View：1

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court rules employers must be more accommodating of religious observance
Next article： The cancer drug shortage isn’t new — and neither are the solutions

comprehensive

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

As Taiwan prepares for anti

FILE-J-10jetfightersperforminformationtocelebratethe60thanniversaryofthePeople'sLiberationArmyAirFor

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

AbbVie dramatically boosts its spending on lobbying

ThepharmagiantAbbViespentnearly$4milliononlobbyinginthefirstthreemonthsof2022—nearlyamilliondollarsm

comprehensive

knowledge

comprehensive

AbbVie dramatically boosts its spending on lobbying